
vTv Therapeutics Inc.
USD37.75
+1.48 (+4.08%)
CEO
Paul J. Sekhri
IPO Date
2015-07-30
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$37.20
Prev. Close
$36.27
Day Low
$36.60
Day High
$38.48
52W Low
$14.00
52W High
$44.00
Market Cap
$0.10B
Volume
0.05M
vTv Therapeutics and Cantex Pharmaceuticals Announce Strategic Licensing Agreement for Development and Commercialization of Azeliragon for Treatment of Cancer